⌘K

Home/Filings/4/0001641172-25-003821

4//SEC Filing

Karah Hila 4

Accession 0001641172-25-003821

CIK 0001857044other

View on SEC.gov Company Profile

Filed

Apr 10, 8:00 PM ET

Accepted

Apr 11, 4:15 PM ET

Size

12.0 KB

Accession

0001641172-25-003821

Insider Transaction Report

Form 4

Period: 2025-04-10

Indaptus Therapeutics, Inc.INDP

Director

Transactions

Disposition to Issuer
Stock Option (right to buy)
2025-04-10$0.39/sh−500$195→ 0 total
Exercise: $24.60From: 2020-07-15Exp: 2027-07-15→ Common Stock (500 underlying)
Disposition to Issuer
Stock Option (right to buy)
2025-04-10$0.39/sh−250$98→ 0 total
Exercise: $388.64From: 2019-06-28Exp: 2026-06-28→ Common Stock (250 underlying)
Disposition to Issuer
Stock Option (right to buy)
2025-04-10$0.39/sh−250$98→ 0 total
Exercise: $355.20From: 2018-06-28Exp: 2025-06-28→ Common Stock (250 underlying)
Disposition to Issuer
Stock Option (right to buy)
2025-04-10$0.39/sh−281$110→ 0 total
Exercise: $480.00From: 2016-05-22Exp: 2026-05-22→ Common Stock (281 underlying)

Footnotes (1)

[F1]The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Indaptus Therapeutics, Inc.

CIK 0001857044

Entity typeother

Related Parties

1

filerCIK 0001668116

Filing Metadata

Form type: 4
Filed: Apr 10, 8:00 PM ET
Accepted: Apr 11, 4:15 PM ET
Size: 12.0 KB

View on SEC.gov